The Tumor Necrosis Factor (TNF) inhibitor drug market has seen remarkable growth in recent years due to the increasing prevalence of autoimmune diseases and chronic inflammatory conditions. TNF inhibitors are a class of biologic drugs that specifically target and inhibit the activity of TNF, a protein involved in systemic inflammation. By blocking TNF, these drugs help manage...